デフォルト表紙
市場調査レポート
商品コード
1206229

ポイントオブケア分子診断の世界市場 - 市場規模(技術別、用途別、最終用途別)、地域の見通し、業界の分析、成長可能性、競合の市場シェア、予測(2023年~2032年)

Point of Care Molecular Diagnostics Market Size by Technology, By Application, By End-use, Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 170 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ポイントオブケア分子診断の世界市場 - 市場規模(技術別、用途別、最終用途別)、地域の見通し、業界の分析、成長可能性、競合の市場シェア、予測(2023年~2032年)
出版日: 2023年01月16日
発行: Global Market Insights Inc.
ページ情報: 英文 170 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポイントオブケア分子診断市場は、緊急の感染症において原因物質を検出できることから、2032年まで成長を記録すると予測されています。

当レポートでは、世界のポイントオブケア分子診断市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ポイントオブケア分子診断業界の考察

  • 業界情勢
  • 価格分析(2018年~2032年)
    • 価格分析:地域別
  • 業界に対する影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 成長可能性分析
    • 技術別
    • 用途別
    • 最終用途別
  • COVID-19の影響の分析
  • 技術情勢
  • 規制情勢
    • 米国
    • 欧州
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc
    • BioM?rieux SA
  • 競合ダッシュボード(2021年)
  • 企業マトリックス分析(2021年)
  • 主な市場企業の競合の分析
  • 競合ポジショニングマトリックス
  • 戦略的見通しマトリックス

第5章 ポイントオブケア分子診断市場:技術別

  • 主な技術の動向
  • ポリメラーゼ連鎖反応(PCR)
  • In situハイブリダイゼーション
  • シーケンシング
  • 等温増幅
  • その他

第6章 ポイントオブケア分子診断市場:用途別

  • 主な用途の動向
  • 感染症
    • 市場の推計と予測(2018年~2032年)
    • インフルエンザ
    • RSウイルス(RSV)
    • 結核(TB)
    • HIV
    • 淋病
    • クラミジア
    • C型肝炎
    • B型肝炎
    • COVID-19
    • その他
  • 腫瘍
  • 血液
  • その他

第7章 ポイントオブケア分子診断市場:最終用途別

  • 主な最終用途の動向
  • 病院
  • 診療所
  • 診断センター
  • その他

第8章 ポイントオブケア分子診断市場:地域別

  • 主な地域の動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • マレーシア
    • タイ
    • ベトナム
    • フィリピン
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • ナイジェリア
    • エジプト
    • モロッコ
    • サウジアラビア
    • アラブ首長国連邦

第9章 企業プロファイル

  • Abbott Laboratories
  • BioM?rieux SA
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • Sysmex Corporation
  • Abaxis Inc
  • Mesa Biotech (Thermo Fisher Scientific)
  • Roche Diagnostics
  • OraSure Technologies, Inc
  • VIRCELL S.L
図表

Data Tables

  • TABLE 1 PoC molecular diagnostics market, 2018- 2032 (USD Million)
  • TABLE 2 PoC molecular diagnostics market, by technology, 2018- 2032 (USD Million)
  • TABLE 3 PoC molecular diagnostics market, by application, 2018- 2032 (USD Mn)
  • TABLE 4 PoC molecular diagnostics market, by end-use, 2018- 2032 (USD Mn)
  • TABLE 5 PoC molecular diagnostics market, by region, 2018- 2032 (USD Million)
  • TABLE 6 Industry impact forces
  • TABLE 7 PCR market size, by region, 2018- 2032 (USD Million)
  • TABLE 8 In Situ Hybridization market size, by region, 2018- 2032 (USD Million)
  • TABLE 9 Sequencing market size, by region, 2018- 2032 (USD Million)
  • TABLE 10 Isothermal amplification market size, by region, 2018- 2032 (USD Million)
  • TABLE 11 Others market size, by region, 2018- 2032 (USD Million)
  • TABLE 12 Infectious disease market size, by region, 2018- 2032 (USD Million)
  • TABLE 13 Flu market size, by region, 2018- 2032 (USD Million)
  • TABLE 14 RSV market size, by region, 2018- 2032 (USD Million)
  • TABLE 15 Tuberculosis market size, by region, 2018- 2032 (USD Million)
  • TABLE 16 HIV market size, by region, 2018- 2032 (USD Million)
  • TABLE 17 Gonorrhea market size, by region, 2018- 2032 (USD Million)
  • TABLE 18 Chlamydia market size, by region, 2018- 2032 (USD Million)
  • TABLE 19 Hepatitis C market size, by region, 2018- 2032 (USD Million)
  • TABLE 20 Hepatitis B market size, by region, 2018- 2032 (USD Million)
  • TABLE 21 Others market size, by region, 2018- 2032 (USD Million)
  • TABLE 22 Oncology market size, by region, 2018- 2032 (USD Million)
  • TABLE 23 Hematology testing market size, by region, 2018- 2032 (USD Mn)
  • TABLE 24 Others market size, by region, 2018- 2032 (USD Million)
  • TABLE 25 Hospitals market size, by region, 2018- 2032 (USD Million)
  • TABLE 26 Clinics market size, by region, 2018- 2032 (USD Million)
  • TABLE 27 Others market size, by region, 2018- 2032 (USD Million)
  • TABLE 28 North America market size, by country, 2018- 2032 (USD Million)
  • TABLE 29 North America market size, by technology, 2018- 2032 (USD Million)
  • TABLE 30 North America market size, by application, 2018- 2032 (USD Million)
  • TABLE 31 North America market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 32 North America market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 33 U.S. market size, by technology, 2018- 2032 (USD Million)
  • TABLE 34 U.S. market size, by application, 2018- 2032 (USD Million)
  • TABLE 35 U.S. market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 36 U.S. market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 37 Canada market size, by technology, 2018- 2032 (USD Million)
  • TABLE 38 Canada market size, by application, 2018- 2032 (USD Million)
  • TABLE 39 Canada market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 40 Canada market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 41 Europe market size, by country, 2018- 2032 (USD Million)
  • TABLE 42 Europe market size, by technology, 2018- 2032 (USD Million)
  • TABLE 43 Europe market size, by application, 2018- 2032 (USD Million)
  • TABLE 44 Europe market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 45 Europe market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 46 Germany market size, by technology, 2018- 2032 (USD Million)
  • TABLE 47 Germany market size, by application, 2018- 2032 (USD Million)
  • TABLE 48 Germany market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 49 Germany market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 50 UK market size, by technology, 2018- 2032 (USD Million)
  • TABLE 51 U.K. market size, by application, 2018- 2032 (USD Million)
  • TABLE 52 U.K. market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 53 UK market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 54 France market size, by technology, 2018- 2032 (USD Million)
  • TABLE 55 France market size, by application, 2018- 2032 (USD Million)
  • TABLE 56 France market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 57 France market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 58 Italy market size, by technology, 2018- 2032 (USD Million)
  • TABLE 59 Italy market size, by application, 2018- 2032 (USD Million)
  • TABLE 60 Italy market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 61 Italy market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 62 Spain market size, by technology, 2018- 2032 (USD Million)
  • TABLE 63 Spain market size, by application, 2018- 2032 (USD Million)
  • TABLE 64 Spain market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 65 Spain market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 66 Russia market size, by technology, 2018- 2032 (USD Million)
  • TABLE 67 Russia market size, by application, 2018- 2032 (USD Million)
  • TABLE 68 Russia market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 69 Russia market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 70 Asia Pacific market size, by country, 2018- 2032 (USD Million)
  • TABLE 71 Asia Pacific market size, by technology, 2018- 2032 (USD Million)
  • TABLE 72 Asia Pacific market size, by application, 2018- 2032 (USD Million)
  • TABLE 73 Asia Pacific market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 74 Asia Pacific market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 75 Japan market size, by technology, 2018- 2032 (USD Million)
  • TABLE 76 Japan market size, by application, 2018- 2032 (USD Million)
  • TABLE 77 Japan market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 78 Japan market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 79 China market size, by technology, 2018- 2032 (USD Million)
  • TABLE 80 China market size, by application, 2018- 2032 (USD Million)
  • TABLE 81 China market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 82 China market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 83 India market size, by technology, 2018- 2032 (USD Million)
  • TABLE 84 India market size, by application, 2018- 2032 (USD Million)
  • TABLE 85 India market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 86 India market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 87 South Korea market size, by technology, 2018- 2032 (USD Million)
  • TABLE 88 South Korea market size, by application, 2018- 2032 (USD Million)
  • TABLE 89 South Korea market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 90 South Korea market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 91 Malaysia market size, by technology, 2018- 2032 (USD Million)
  • TABLE 92 Malaysia market size, by application, 2018- 2032 (USD Million)
  • TABLE 93 Malaysia market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 94 Malaysia market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 95 Thailand market size, by technology, 2018- 2032 (USD Million)
  • TABLE 96 Thailand market size, by application, 2018- 2032 (USD Million)
  • TABLE 97 Thailand market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 98 Thailand market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 99 Vietnam market size, by technology, 2018- 2032 (USD Million)
  • TABLE 100 Vietnam market size, by application, 2018- 2032 (USD Million)
  • TABLE 101 Vietnam market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 102 Vietnam market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 103 Philippines market size, by technology, 2018- 2032 (USD Million)
  • TABLE 104 Philippines market size, by application, 2018- 2032 (USD Million)
  • TABLE 105 Philippines market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 106 Philippines market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 107 Australia market size, by technology, 2018- 2032 (USD Million)
  • TABLE 108 Australia market size, by application, 2018- 2032 (USD Million)
  • TABLE 109 Australia market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 110 Australia market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 111 Latin America market size, by country, 2018- 2032 (USD Million)
  • TABLE 112 Latin America market size, by technology, 2018- 2032 (USD Million)
  • TABLE 113 Latin America market size, by application, 2018- 2032 (USD Million)
  • TABLE 114 Latin America market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 115 Latin America market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 116 Brazil market size, by technology, 2018- 2032 (USD Million)
  • TABLE 117 Brazil market size, by application, 2018- 2032 (USD Million)
  • TABLE 118 Brazil market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 119 Brazil market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 120 Mexico market size, by technology, 2018- 2032 (USD Million)
  • TABLE 121 Mexico market size, by application, 2018- 2032 (USD Million)
  • TABLE 122 Mexico market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 123 Mexico market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 124 Argentina market size, by technology, 2018- 2032 (USD Million)
  • TABLE 125 Argentina market size, by application, 2018- 2032 (USD Million)
  • TABLE 126 Argentina market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 127 Argentina market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 128 MEA market size, by country, 2018- 2032 (USD Million)
  • TABLE 129 MEA market size, by technology, 2018- 2032 (USD Million)
  • TABLE 130 MEA market size, by application, 2018- 2032 (USD Million)
  • TABLE 131 MEA market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 132 MEA market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 133 South Africa market size, by technology, 2018- 2032 (USD Million)
  • TABLE 134 South Africa market size, by application, 2018- 2032 (USD Million)
  • TABLE 135 South Africa market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 136 South Africa market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 137 Nigeria market size, by technology, 2018- 2032 (USD Million)
  • TABLE 138 Nigeria market size, by application, 2018- 2032 (USD Million)
  • TABLE 139 Nigeria market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 140 Nigeria market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 141 Egypt market size, by technology, 2018- 2032 (USD Million)
  • TABLE 142 Egypt market size, by application, 2018- 2032 (USD Million)
  • TABLE 143 Egypt market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 144 Egypt market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 145 Morocco market size, by technology, 2018- 2032 (USD Million)
  • TABLE 146 Morocco market size, by application, 2018- 2032 (USD Million)
  • TABLE 147 Morocco market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 148 Morocco market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 149 Saudi Arabia market size, by technology, 2018- 2032 (USD Million)
  • TABLE 150 Saudi Arabia market size, by application, 2018- 2032 (USD Million)
  • TABLE 151 Saudi Arabia market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 152 Saudi Arabia market size, by end-use, 2018- 2032 (USD Million)
  • TABLE 153 UAE market size, by technology, 2018- 2032 (USD Million)
  • TABLE 154 UAE market size, by application, 2018- 2032 (USD Million)
  • TABLE 155 UAE market size, by infectious disease, 2018- 2032 (USD Million)
  • TABLE 156 UAE market size, by end-use, 2018- 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Point of care molecular diagnostics industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Global point of care molecular diagnostics market, by region, 2018 - 2032 (USD Million)
  • FIG. 9 Growth potential analysis, by technology
  • FIG. 10 Growth potential analysis, by application
  • FIG. 11 Growth potential analysis, by end use
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Competitive dashboard, 2021
  • FIG. 15 Company matrix analysis, 2021
  • FIG. 16 Competitive analysis of major market players, 2021
  • FIG. 17 Competitive positioning matrix
  • FIG. 18 Strategic outlook matrix
目次
Product Code: 2210

Point of Care Molecular Diagnostics Market is anticipated to register growth through 2032 owing to its ability to detect causative agents in case of any infectious disease emergencies. POC molecular testing plays a vital role in TAT (turnaround time). It offers access to rapid and sensitive infectious disease diagnostic assays crucial for timely infection control, effective treatment, and accurate diagnosis.

The COVID-19 outbreak has underscored the need to detect the disease rapidly and accurately at much higher scales than ever before. Several benefits offered by point-of-care devices such as the possibility of using more portable and cost-effective instrumentation; eliminating sample transport to a clinical laboratory for analysis; alleviating sample processing; using samples that hardly require trained personnel for collection; and measuring different entities (virus, antigen, antibodies) in symptomatic or asymptomatic patients will spur the product adoption in the coming future.

Besides, strategic initiatives by various governmental bodies, such as funds and grants to support the development of novel products, will also positively influence the overall industry growth. For instance, in 2021, Thermo Fisher Scientific unveiled a manufacturing facility in India. The company's MagMAX Dx prefilled viral/pathogen nucleic acid isolation kits and CoviPath RT-PCR testing kits are developed to offer more precise, faster, and easy-to-use Covid testing solutions.

Overall, the point-of-care molecular diagnostics market is segmented in terms of technology, application, end-use, and region.

Based on technology, the polymerase chain reaction (PCR) diagnostic test segment will register notable gains through 2032. Factors such as the budding use in research and development, medical diagnostics, constant technological advancements, increasing prevalence of diseases, and a rising geriatric population base would add to the segmental expansion.

Considering the application, the infectious disease segment accounted for 80% market share in 2022. The increasing prevalence of respiratory syncytial virus and influenza and the easy availability of rapid diagnostic tests, including screening tests for influenza A and B virus infections, will propel segmental demand over the estimated timeframe.

By end-use, the clinics segment accounted for over USD 10 billion revenue share in 2022. The increasing number of clinics, along with cost-effective treatment and portable point-of-care molecular diagnostics systems that help with accurate and timely diagnostics, will spur market growth by 2032 end.

Regionally, the North America point-of-care molecular diagnostics market will register notable gains throughout 2023-2032. The growth can be attributed to the increasing adoption of point-of-care molecular diagnostics and treatment devices equipped with advanced technology. Also, some of the leading regional market players are constantly investing in R&D and increasing their focus on launching novel products, bolstering regional market growth in the future.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates and calculations
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Point of care molecular diagnostics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Technology trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Point of Care Molecular Diagnostics Industry Insights

  • 3.1 Industry landscape
  • 3.2 Pricing analysis 2018 - 2032
    • 3.2.1 Pricing analysis, by region
      • 3.2.1.1 North America
      • 3.2.1.2 Europe
      • 3.2.1.3 Asia Pacific
      • 3.2.1.4 Latin America
      • 3.2.1.5 Middle East & Africa
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing incidence of infectious diseases
      • 3.3.1.2 Increasing R&D funding to reduce time required for molecular diagnostic tests
      • 3.3.1.3 Growing awareness about pre-disease diagnostics to control occurrence of diseases
      • 3.3.1.4 Technological advancements in DNA sequencing and analysis
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Long product development time
      • 3.3.2.2 Complex regulatory process
  • 3.4 Growth potential analysis
    • 3.4.1 By technology
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 COVID- 19 impact analysis
  • 3.6 Technology landscape
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape

  • 4.1 Introduction
    • 4.1.1 Abbott Laboratories
    • 4.1.2 Bio-Rad Laboratories, Inc
    • 4.1.3 BioMérieux SA
  • 4.2 Competitive dashboard, 2021
  • 4.3 Company matrix analysis, 2021
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic outlook matrix

Chapter 5 Point of Care Molecular Diagnostics Market, By Technology

  • 5.1 Key technology trends
  • 5.2 Polymerase Chain Reaction (PCR)
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 In situ hybridization
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Sequecing
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Isothermal amplification
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.6 Others
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Point of Care Molecular Diagnostics Market, By Application

  • 6.1 Key application trends
  • 6.2 Infectious diseases
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.2 Flu
      • 6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.3 Respiratory syncytial virus (RSV)
      • 6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.4 Tuberculosis (TB)
      • 6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.5 HIV
      • 6.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.6 Gonorrhea
      • 6.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.7 Chlamydia
      • 6.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.8 Hepatitis C
      • 6.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.9 Hepatitis B
      • 6.2.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.10 COVID-19
      • 6.2.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 6.2.11 Others
      • 6.2.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Oncology
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Hematology
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Others
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Point of Care Molecular Diagnostics Market, By End-use

  • 7.1 Key end-use trends
  • 7.2 Hospitals
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Clinics
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Diagnostic centers
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Others
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Point of Care Molecular Diagnostics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Malaysia
    • 8.4.6 Thailand
    • 8.4.7 Vietnam
    • 8.4.8 Philippines
    • 8.4.9 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Nigeria
    • 8.6.3 Egypt
    • 8.6.4 Morocco
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 BioMérieux SA
  • 9.3 Bio-Rad Laboratories, Inc
  • 9.4 Danaher Corporation
  • 9.5 Sysmex Corporation
  • 9.6 Abaxis Inc
  • 9.7 Mesa Biotech (Thermo Fisher Scientific)
  • 9.8 Roche Diagnostics
  • 9.9 OraSure Technologies, Inc
  • 9.10 VIRCELL S.L